Checkpoint inhibitor therapy for skin cancer may be safe in patients with asymptomatic COVID-19

Detalles Bibliográficos
Autores principales: Trojaniello, C., Vitale, M.G., Ascierto, P.A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Society for Medical Oncology. Published by Elsevier Ltd. 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884251/
https://www.ncbi.nlm.nih.gov/pubmed/33600920
http://dx.doi.org/10.1016/j.annonc.2021.02.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884251/
https://www.ncbi.nlm.nih.gov/pubmed/33600920
http://dx.doi.org/10.1016/j.annonc.2021.02.008

Ejemplares similares